Evidence map›Paper›PMID 35181768›Full record

ArticleNature medicine2022

Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Mohsen Malehmir, Dominik Pfister, Suchira Gallage, Marta Szydlowska, Donato Inverso, Elena Kotsiliti, Valentina Leone, Moritz Peiseler, Bas G J Surewaard, Dominik Rath and 57 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

67 authors at 20 institutions in 8 countries.

Mohsen Malehmir *Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.
Dominik Pfister *Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
Suchira Gallage *Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
Marta Szydlowska *Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-4660-899X
Donato Inverso *Division of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0987-3345
Elena KotsilitiDivision of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
Valentina LeoneDivision of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
Moritz PeiselerCalvin Phoebe & Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Bas G J SurewaardDepartment of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Dominik RathDepartment of Cardiology and Circulatory Diseases, Internal Medicine Clinic III, Eberhard Karls University Tübingen, Tübingen, Germany.
Adnan AliDivision of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
Monika Julia WolfDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.
Hannah DrescherDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Marc E HealyDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.
Daniel DauchDepartment of Internal Medicine VIII, University Hospital Tübingen, Tübingen, Germany.
Daniela KroyDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Oliver KrenkelDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Marlene KohlheppDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Thomas EngleitnerCenter for Translational Cancer Research (TranslaTUM), Technische Universität München, Munich, Germany.
Alexander OlkusDivision of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
Tjeerd SijmonsmaDivision of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
Julia VolzInstitute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
Carsten DeppermannInstitute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0003-3740-8635
David StegnerInstitute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0003-1059-9865
Patrick HelblingHematology, University Hospital and University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-6488-2805
César Nombela-ArrietaHematology, University Hospital and University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-0415-259X
Anahita RafieiHematology, University Hospital and University of Zurich, Zurich, Switzerland.
Martina HinterleitnerDepartment of Internal Medicine VIII, University Hospital Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0001-7137-0541
Marcel RallDepartment of Cardiology and Circulatory Diseases, Internal Medicine Clinic III, Eberhard Karls University Tübingen, Tübingen, Germany.
Florian BakuDepartment of Cardiology and Circulatory Diseases, Internal Medicine Clinic III, Eberhard Karls University Tübingen, Tübingen, Germany.
Oliver BorstDepartment of Cardiology and Circulatory Diseases, Internal Medicine Clinic III, Eberhard Karls University Tübingen, Tübingen, Germany.
Caroline L WilsonNewcastle Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK.
Jack LeslieNewcastle Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK.
Tracy O'ConnorInstitute for Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
Christopher J WestonCentre for Liver Research and National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit, Birmingham, UK.ORCID http://orcid.org/0000-0002-9651-1264
Abhishek ChauhanCentre for Liver Research and National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit, Birmingham, UK.
David H AdamsCentre for Liver Research and National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit, Birmingham, UK.
Lozan SheriffInstitute for Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
Ana TeijeiroCancer Cell Biology Programme, Growth Factors, Nutrients and Cancer Group, Spanish National Cancer Research Centre, CNIO, Madrid, Spain.
Marco PrinzInstitute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
Ruzhica BogeskaDivision of Experimental Hematology, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
Natasha AnsteeDivision of Experimental Hematology, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
Malte N BongersDepartment of Diagnostic and Interventional Radiology, University Hospital of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0003-2852-0270
Mike NotohamiprodjoDepartment of Diagnostic and Interventional Radiology, University Hospital of Tübingen, Tübingen, Germany.
Tobias GeislerDepartment of Cardiovascular Medicine, University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany.
Dominic J WithersMetabolic Signalling Group, MRC London Institute of Medical Sciences, London, UK.ORCID http://orcid.org/0000-0002-8009-7521
Jerry WareDepartment of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID http://orcid.org/0000-0001-8860-6338
Derek A MannNewcastle Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK.
Hellmut G AugustinDivision of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany.
Alexandros VegiopoulosDKFZ Junior Group Metabolism and Stem Cell Plasticity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Michael D MilsomDivision of Experimental Hematology, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
Adam J RoseNutrient Metabolism and Signalling Lab, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, and Metabolism, Diabetes and Obesity Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.ORCID http://orcid.org/0000-0001-9132-8244
Patricia F LalorCentre for Liver Research and National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit, Birmingham, UK.
Josep M LlovetMount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Medicine, Department of Pathology, Recanati Miller Transplantation Institute), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-0547-2667
Roser PinyolLiver Cancer Translational Research Laboratory, IDIBAPS, Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalonia, Spain.
Frank TackeDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Roland RadCenter for Translational Cancer Research (TranslaTUM), Technische Universität München, Munich, Germany.
Matthias MatterInstitute of Pathology, University Hospital of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-2005-5266
Nabil DjouderCancer Cell Biology Programme, Growth Factors, Nutrients and Cancer Group, Spanish National Cancer Research Centre, CNIO, Madrid, Spain.
Paul KubesCalvin Phoebe & Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID http://orcid.org/0000-0002-2835-4244
Percy A KnolleInstitute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-2983-0414
Kristian UngerResearch Unit of Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Lars ZenderDepartment of Internal Medicine VIII, University Hospital Tübingen, Tübingen, Germany.
Bernhard NieswandtInstitute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
Meinrad GawazDepartment of Cardiology and Circulatory Diseases, Internal Medicine Clinic III, Eberhard Karls University Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0003-1124-9592
Achim WeberDepartment of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland. achim.weber@usz.ch.ORCID http://orcid.org/0000-0003-0073-3637
Mathias HeikenwalderDivision of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany. heikenwaelder@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0002-3135-2274
German Cancer Research Center · DEUniversity of Tübingen · DERWTH Aachen University · DEUniversity Hospital of Zurich · CHUniversity of Würzburg · DENational Institute for Health Research · GBNewcastle University · GBUniversity of Calgary · CAUniversity of Zurich · CHHelmholtz Zentrum München · DESpanish National Cancer Research Centre · ESUniversity Children's Hospital Tübingen · DEConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESInstitució Catalana de Recerca i Estudis Avançats · ESMonash University · AUMRC London Institute of Medical Sciences · GBTechnical University of Munich · DEUniversity Hospital of Basel · CHUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Arkansas for Medical Sciences · US

Funding

Cancer Research UK 23390Medical Research Council MR/R023026/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35181768
OpenAlexW4212862976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.